Differential diagnosis: distinguishing between ghostwriting and professional medical writing in biomedical journals.

Differential diagnosis: distinguishing between ghostwriting and professional medical writing in biomedical journals.
复制标题

鉴别诊断:区分生物医学期刊中的代笔和专业医学写作。

DOI:
10.1001/jamainternmed.2013.10420
复制
发表时间:
2013
影响因子:
39
通讯作者:
Cindy W. Hamilton
Cindy W. Hamilton
中科院分区:
医学1区
文献类型:
--
作者:
Cindy W. Hamilton

文献摘要

被引文献

相似文献

但这些产品不是膳食补充剂,这与 Harel 等人最近发表的研究信中的主张相反。1 作者正确地识别了膳食补充剂中允许存在的许多成分,包括维生素、矿物质、草药和氨基酸。但西布曲明或西地那非等药物成分不得用于补充剂,并且含有这些成分的产品不符合联邦对膳食补充剂的定义。此类产品也不能正确归类为药品,因为它们不是经过批准的药品。然而,无论如何识别这些非法商品,可以肯定的是,无论何时何地出售,它们都是非法的。可以肯定的是,这些非法产品给消费者带来了重大的健康风险,这是文章作者和美国补充剂行业的共同担忧。这就是为什么我们的组织和其他组织与美国食品和药物管理局 (FDA) 密切合作,呼吁人们关注这一持续存在的问题,并表达对 FDA 积极执法的强烈支持。作者认为,膳食补充剂健康和教育法案 2 (DSHEA)“允许将许多通常含有活性药物成分的补充剂产品引入市场。”1(p927) 这不是事实。相反,这些产品的销售者无视美国3以及其他销售这些危险品的国家的法律。
But these products are not dietary supplements, contrary to assertions in the recently published Research Letter authored by Harel et al.1 The authors correctly identify many of the ingredients that are allowed to be present in dietary supplements, including vitamins, minerals, herbs, and amino acids. But pharmaceutical ingredients—such as sibutramine or sildenafil—may not be used in supplements, and products that contain these fail to meet the federal definition of dietary supplements. Nor are such products properly classified as drugs, since they are not approved drug products. Irrespective of how these illegal goods should be identified, however, it is certain that they are unlawful whenever and wherever they are sold. It is also certain that these illegal products present significant health risks to consumers, a concern that is shared by the article’s authors and the US supplement industry. That is why our organization and others have worked closely with the Food and Drug Administration (FDA) to call attention to this ongoing problem and to express strong support for active enforcement by the FDA. The authors suggest that the Dietary Supplement Health and Education Act2 (DSHEA) “has permitted the introduction of numerous supplement products, often containing active pharmaceutical ingredient, into the marketplace.”1(p927) This is not true. Rather, these products are marketed by those who ignore the laws of the United States3 and of every other country in which these dangerous goods are available.